Dr. David Karpik Optometrist Medicare: Accepting Medicare Assignments Practice Location: 110 S Willow St Ste 108, Kenai, AK 99611 Phone: 907-283-7575 Fax: 907-283-6156 |
Dr. Dennis A Swarner, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 110 S Willow St, Unit #108, Kenai, AK 99611 Phone: 907-283-7575 Fax: 907-283-6156 |
Dr. Kathleen J Rice, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 110 S Willow St Ste 108, Kenai, AK 99611 Phone: 907-283-7575 Fax: 907-283-6156 |
Alfonso Lamendola Sitenga, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 115 Bidarka St, Kenai, AK 99611 Phone: 907-335-3358 |
Dr. William M Phillips, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 508 Upland Street, Kenai, AK 99611 Phone: 907-335-7500 |
Dr. Lisa Frederickson, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 508 Upland St, Kenai, AK 99611 Phone: 907-335-7305 Fax: 888-491-3360 |
Prism Eye Associates Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3137 Tongass Ave Ste C, Ketchikan, AK 99901 Phone: 907-885-3999 |
Mr. Ricky Dean Swearingen, OD OPTOMETRIST Optometrist Medicare: May Accept Medicare Assignments Practice Location: 351 Carlanna Lake Road, Ketchikan, AK 99901 Phone: 907-225-2020 Fax: 907-247-2015 |
Ketchikan Eye Care Center, L.l.c. Optometrist Medicare: Medicare Enrolled Practice Location: 351 Carlanna Lake Rd, Ketchikan, AK 99901 Phone: 907-225-2020 Fax: 907-247-2015 |
Erik D Christianson, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 351 Carlanna Lake Rd, Ketchikan, AK 99901 Phone: 907-225-2020 Fax: 907-247-2015 |
Kodiak Vision Clinic & Sally's Eyeland, Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 214 W Rezanof Dr, Kodiak, AK 99615 Phone: 907-486-6117 |
Dr. Jerimiah L Myers, OD Optometrist Medicare: Medicare Enrolled Practice Location: 214 W Rezanof, Ste 1, Kodiak, AK 99615 Phone: 907-486-6117 Fax: 907-486-6140 |
Eyecare Excellence A Professional Corporation Optometrist Medicare: Medicare Enrolled Practice Location: 3450 E. Rezanof Dr., Kodiak, AK 99615 Phone: 907-486-5504 Fax: 907-486-6577 |
Alaska Vision Center Optometrist Medicare: Medicare Enrolled Practice Location: 214 W Rezanof Dr, Kodiak, AK 99615 Phone: 907-486-6117 |
John Shank, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3450 E. Rezanof Dr., Kodiak, AK 99615 Phone: 907-486-5504 |
Desiree Alexis Wheeler, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3450 E Rezanof Dr, Kodiak, AK 99615 Phone: 907-486-5504 |
Meagan Lincoln, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 436 5th Avenue, Kotzebue, AK 99752 Phone: 907-442-7275 |
Dr. Kamey Kapp, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 309 Bering Street, #1049, Nome, AK 99762 Phone: 907-443-3553 Fax: 844-901-4313 |
Akshay Sanjay Patil, OD Optometrist Medicare: Medicare Enrolled Practice Location: 1000 Greg Kruschek Avenue, Nome, AK 99762 Phone: 907-443-3311 |
Tundra Health Initiative Corp Optometrist Medicare: Not Enrolled in Medicare Practice Location: 309 Bering St, #1049, Nome, AK 99762 Phone: 907-443-3553 Fax: 844-901-4313 |
News Archive
Spacelabs Healthcare today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for the Blease900 Ventilator - an integral component of its BleaseFocus anesthesia system - paving the way for launch of the new BleaseFocus anesthesia system to healthcare facilities in the United States.
Scientists from the Florida campus of The Scripps Research Institute have been awarded $2.1 million from the National Institute of Neurological Disorders and Stroke of The National Institutes of Health (NIH) to study a protein that has been closely linked in animal models to Parkinson's disease and Huntington's disease.
Research reported in the October issue of The Journal of Nuclear Medicine (JNM) shows that a molecular imaging technique may prove useful in early assessment of treatment response for cisplatin-resistant ovarian cancer.
"The Natural Products Association and its members are very excited to see the DEA use the additional power the NPA and many others worked so hard to give to it through the Anabolic Steroid Control Act of 2004.
AbbVie, a research-based global biopharmaceutical company, today announced positive results from U-ACHIEVE, an ongoing Phase 2b/3 dose-ranging study evaluating upadacitinib, an investigational JAK1-selective inhibitor, for induction and maintenance therapy in adult patients with moderately to severely active ulcerative colitis.
› Verified 3 days ago